David J. Riese

5.2k citations

53 papers · 4.1k indexed · 1 hit paper · h-index 31

Impact in

Oncology top 1%
- HER2/EGFR in Cancer Research
- Cytokine Signaling Pathways and Interactions
Radiology, Nuclear Medicine and Imaging top 1%
- Monoclonal and Polyclonal Antibodies Research

Papers in

Oncology 43
- HER2/EGFR in Cancer Research 39
- Bone health and treatments 3
Radiology, Nuclear Medicine and Imaging 28
- Monoclonal and Polyclonal Antibodies Research 28

Co-authors: David F. Stern Gregory D. Plowman Jennifer L. Gilmore Jianzhong Shen John Foley Yi Shi Kristy J. Wilson Glenn C. Andrews
Journals: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (3 papers)Journal of Biological Chemistry (3 papers)Growth Factors (3 papers)Journal of Virology (3 papers)Biochemical and Biophysical Research Communications (2 papers)
Partner nations: United States Germany France

In The Last Decade

David J. Riese

53 papers receiving 4.1k citations

Hit Papers

align trajectories log scale

Specificity within the EGF family/ErbB receptor family signaling network 1998 · 671 citations

Peers

Countries citing papers authored by David J. Riese

Since Specialization

Citations

This map shows the geographic impact of David J. Riese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Riese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Riese more than expected).

Fields of papers citing papers by David J. Riese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Riese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Riese. The network helps show where David J. Riese may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David J. Riese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David J. Riese Line = papers co-authored together David J. Riese links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics PLoS ONE ·Lucas Weinberg, Chamali Gajaweera, Ana Paula Alencar Moura, John T. Piazza, Y. S. Gasimov, Kanupriya Whig, Ling Zhai, 尚子内, Frank Chlebana, M Li, 秀彦高良, Dimitris Komiotis, Christopher P. Mill, A Muggia, Forrest Smith, Mark J. Suto, Robert Bostwick, Ram B. Gupta, Allan E. David, David J. Riese	2020	2
2	Team-Based Learning in US Colleges and Schools of Pharmacy American Journal of Pharmaceutical Education ·M Szolytsik, L.A.Y. Tumober, Andrea S. Franks, Reza Karimi, Marianne McCollum, David J. Riese, Anne Lin	2013	96
3	The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist Biochemical Journal ·Kristy J. Wilson, Christopher P. Mill, Richard L. Gallo, Elizabeth Cameron, Henry F. VanBrocklin, Jeffrey Settleman, David J. Riese	2012	5
4	EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling Growth Factors ·Kristy J. Wilson, Christopher P. Mill, Yi-xin WU, Hazel D. Brogdon, Timothy R. Wilson, Victor Hernandez‐Gordillo, Richard L. Gallo, F.R. Schram, Jeffrey Settleman, David J. Riese	2012	95
5	EGFR signaling in breast cancer: Bad to the bone Seminars in Cell and Developmental Biology ·John Foley, 准二中村, Seungyoon Nam, Marcio Ramos Junqueira, Jennifer L. Gilmore, Kenneth P. Nephew, David J. Riese	2010	125
6	Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop Cellular Signalling ·Nicole E. Willmarth, Karen Julieth Gómez Isaza, Michele Dziubinski, Kristy J. Wilson, David J. Riese, Stephen P. Ethier	2008	66
7	Oncogenic Activity of Epidermal Growth Factor Receptor Kinase Mutant Alleles Is Enhanced by the T790M Drug Resistance Mutation Cancer Research ·Nadia Godin-Heymann, Кhava N. Temaeva, Miguel N. Rivera, Lindsey Ulkus, Daphne W. Bell, David J. Riese, Jeffrey Settleman, Daniel A. Haber	2007	120
8	Inter-conversion of neuregulin2 full and partial agonists for ErbB4 Biochemical and Biophysical Research Communications ·Kristy J. Wilson, Christopher P. Mill, Elizabeth Cameron, Stuart Hobbs, Robert P. Hammer, David J. Riese	2007	13
9	Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis BioEssays ·David J. Riese, Richard L. Gallo, Jeffrey Settleman	2007	73
10	The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056 Growth Factors ·Richard L. Gallo, David J. Riese	2007	4
11	Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines Biochemical and Biophysical Research Communications ·Richard L. Gallo, Кhava N. Temaeva, Brady Aebersold, Eric E. Williams, David J. Riese	2006	19
12	Anilinodialkoxyquinazolines: Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Potential Tumor Imaging Probes Journal of Medicinal Chemistry ·Henry F. VanBrocklin, John K. C. Lim, Stephanie L. Coffing, Ravindu Goonawardene, Udoka Okeke Chukwubike, Gregor Čok, Jennifer L. Gilmore, Кhava N. Temaeva, David J. Riese	2005	30
13	Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase Oncogene ·Stuart Hobbs, Elizabeth Cameron, Robert P. Hammer, Zitong Liu, Richard L. Gallo, 黄佩芬, Stephanie L. Coffing, Han Chang, David J. Riese	2003	23
14	ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation Cellular Signalling ·Silvia Bruni, Eric E. Williams, David J. Riese	2002	16
15	Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities. PubMed ·Lucas Rodrigues, Кhava N. Temaeva, David J. Riese	2002	26
16	Specificity within the EGF family/ErbB receptor family signaling network BioEssays ·David J. Riese, David F. Stern Hit paper breakdown →	1998	671
17	Activation of ErbB4 by the Bifunctional Epidermal Growth Factor Family Hormone Epiregulin Is Regulated by ErbB2 Journal of Biological Chemistry ·David J. Riese, Toshi Komurasaki, Gregory D. Plowman, David F. Stern	1998	86
18	Ligands for ErbB-family receptors encoded by a neuregulin-like gene Nature ·Han Chang, David J. Riese, Walter Gilbert, David F. Stern, U.J. McMahan	1997	239
19	The Epidermal Growth Factor Receptor Couples Transforming Growth Factor-α, Heparin-binding Epidermal Growth Factor-like Factor, and Amphiregulin to Neu, ErbB-3, and ErbB-4 Journal of Biological Chemistry ·David J. Riese, Edward D. Kim, Klaus Elenius, Andrew P. Heim, Michael Klagsbrun, Gregory D. Plowman, David F. Stern	1996	140
20	The Cellular Response to Neuregulins Is Governed by Complex Interactions of the erbB Receptor Family Molecular and Cellular Biology ·David J. Riese, Mikael Forsberg, Gregory D. Plowman, Glenn C. Andrews, David F. Stern	1995	307

About David J. Riese

David J. Riese is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 53 papers that have together received 4.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (39 papers), Monoclonal and Polyclonal Antibodies Research (28 papers), Glycosylation and Glycoproteins Research (16 papers), Lung Cancer Treatments and Mutations (7 papers), Virus-based gene therapy research (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Cell Adhesion Molecules Research (4 papers) and Bone health and treatments (3 papers). The work is most often cited by research in Oncology (2.4k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations), Immunology and Allergy (276 citations), Molecular Biology (2.1k citations) and Cancer Research (342 citations). David J. Riese has collaborated with scholars based in United States, Germany and France. Frequent co-authors include David F. Stern, Gregory D. Plowman, Jennifer L. Gilmore, Jianzhong Shen, John Foley, Yi Shi, Kristy J. Wilson, Glenn C. Andrews, Daniel DiMaio and Richard L. Gallo. Their work appears in journals such as Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Journal of Biological Chemistry, Growth Factors, Journal of Virology and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact